SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, NARI, IRTC, and INSP
Should you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.
Solventum vs.
GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, community ranking, profitability, institutional ownership, earnings and valuation.
GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.
In the previous week, GE HealthCare Technologies had 5 more articles in the media than Solventum. MarketBeat recorded 22 mentions for GE HealthCare Technologies and 17 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 1.51 beat Solventum's score of 1.36 indicating that GE HealthCare Technologies is being referred to more favorably in the media.
GE HealthCare Technologies received 29 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 62.00% of users gave GE HealthCare Technologies an outperform vote while only 7.41% of users gave Solventum an outperform vote.
GE HealthCare Technologies has a net margin of 10.13% compared to Solventum's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Solventum's return on equity.
GE HealthCare Technologies currently has a consensus price target of $88.27, suggesting a potential upside of 26.87%. Solventum has a consensus price target of $80.29, suggesting a potential upside of 10.22%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe GE HealthCare Technologies is more favorable than Solventum.
82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by insiders. Comparatively, 0.1% of Solventum shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
GE HealthCare Technologies beats Solventum on 17 of the 18 factors compared between the two stocks.
Get Solventum News Delivered to You Automatically
Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Solventum Competitors List
Related Companies and Tools
This page (NYSE:SOLV) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy SOLV Stock Free SOLV Stock Alerts